Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Executive or director change
  3. 8-K Event Regulation FD disclosure
  4. 8-K Event Material agreement · Acquisition or sale completed · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shareholder vote results · Director nominations · Regulation FD disclosure
  5. 425 Deal Prospectus/Communication re Business Combination
  6. 8-K Event Other events
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 8-K Event Other events
  9. 425 Deal Prospectus/Communication re Business Combination
  10. S-4/A Deal Registration Statement - Business Combination
  11. S-4/A Deal Registration Statement - Business Combination
  12. 425 Deal Prospectus/Communication re Business Combination
  13. S-4/A Deal Registration Statement - Business Combination
  14. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
  15. S-4 Deal Registration Statement - Business Combination
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
  19. 8-K Event Shareholder vote results
  20. 8-K Event Executive or director change

Page 3 of 9 · 163 filings